COMPOSITIONS FOR CONTAINERS AND OTHER ARTICLES AND METHODS OF USING SAME

(19)

(11)

EP 2 882 819 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	19.12.2018 Bulletin 2018/51

(45)	Mention of the grant of the patent:
	03.10.2018 Bulletin 2018/40

(21)	Application number: 13827304.0

(22)	Date of filing: 08.08.2013

(51)

International Patent Classification (IPC):

C09D 171/00^(2006.01)
B05D 7/14^(2006.01)
C08G 65/26^(2006.01)
B65D 81/34^(2006.01)

C09D 163/02^(2006.01)
B65D 1/12^(2006.01)
B65D 25/14^(2006.01)
C09D 171/12^(2006.01)

(86)	International application number:
	PCT/US2013/054132

(87)	International publication number:
	WO 2014/025997 (13.02.2014 Gazette 2014/07)

(54)	COMPOSITIONS FOR CONTAINERS AND OTHER ARTICLES AND METHODS OF USING SAME GEGENSTÄNDE UND VERFAHREN FÜR DEREN VERWENDUNG COMPOSITIONS POUR DES RÉCIPIENTS ET D'AUTRES ARTICLES ET LEURS PROCÉDÉS D'UTILISATION

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

09.08.2012 US 201261681434 P

(43)	Date of publication of application:
	17.06.2015 Bulletin 2015/25

(60)	Divisional application:
	18197657.2

(73)	Proprietor: SWIMC LLC
	Cleveland, Ohio 44115 (US)

(72)	Inventors:
	NIEDERST, Jeffrey Minneapolis, MN 55440-1461 (US) EVANS, Richard, H. Minneapolis, MN 55440-1461 (US) O'BRIEN, Robert, M. Minneapolis, MN 55440-1461 (US) ROMAGNOLI, Kevin Minneapolis, MN 55440-1461 (US) VON MAIER, Mark, S. Minneapolis, MN 55440-1461 (US)

(74)	Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB
	Siebertstrasse 3 81675 München 81675 München (DE)

(56)

References cited: :

WO-A1-95/26997
WO-A2-2011/130671
JP-B2- 3 484 546
US-A1- 2007 087 146

WO-A2-2011/130671
JP-A- H07 138 502
US-A1- 2005 215 670
US-A1- 2007 087 146

"TEST METHOD NOMINATION: MCF-7 CELL PROLIFERATION ASSAY OF ESTROGENIC ACTIVITY This nomination application includes no confidential information. TABLE OF CONTENTS Page # I Executive Summary 2 1.0 Introduction and Rationale for the Proposed Test Method 6 2.0 Test Method Protocol Components 16 3.0 Subs", , 1 June 2007 (2007-06-01), XP055258155, Retrieved from the Internet: URL:http://ntp.niehs.nih.gov/iccvam/method s/endocrine/endodocs/submdoc.pdf [retrieved on 2016-03-14]
SHIGEYUKI KITAMURA ET AL: "Comparative Study of the Endocrine-Disrupting Activity of Bisphenol A and 19 Related Compounds", TOXICOLOGICAL SCIENCES, ACADEMIC PRESS, vol. 84, no. 2, 1 February 2005 (2005-02-01), pages 249-259, XP002657107, ISSN: 1096-6080, DOI: 10.1093/TOXSCI/KFI074

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).